YZY Bio Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
68
- Stock Symbol
-
02496
- Share Price
-
$0.54
- (As of Monday Closing)
YZY Bio General Information
Description
Wuhan YZY Biopharma Co Ltd is a biotechnology company dedicated to developing bispecific antibody (BsAb)- based therapies. The Company has been forward-looking in deploying its presence in several therapeutic fields, including but not limited to tumor-associated complications, tumors, ophthalmology, and autoimmune diseases. The Company also proactively established several self-developed technology platforms, such as Y-BODY, Check-Body, and Nano-Ybody, promoting the development of more candidates to clinical stages with high efficiency.
Contact Information
Website
www.yzybio.comCorporate Office
- No. 666, Gaoxin Avenue
- East Lake New Technology Development Zone
- Wuhan, Hubei
- China
Corporate Office
- No. 666, Gaoxin Avenue
- East Lake New Technology Development Zone
- Wuhan, Hubei
- China
YZY Bio Stock Performance
As of 16-Nov-2026, YZY Bio’s stock price is $0.54. Its current market cap is $107M with 194M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.54 | $0.51 | $0.28 - $1.08 | $107M | 194M | 100.00 | -$0.02 |
YZY Bio Financials Summary
As of 30-Jun-2026, YZY Bio has a trailing 12-month revenue of $8.98M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 101,204 | 198,453 | 200,972 | 212,609 |
| Revenue | 8,977 | 9,297 | 15,025 | 0 |
| EBITDA | (3,823) | (10,582) | (12,475) | (25,873) |
| Net Income | (4,596) | (11,783) | (13,602) | (27,096) |
| Total Assets | 26,057 | 25,013 | 36,690 | 42,551 |
| Total Debt | 20,406 | 18,260 | 17,446 | 12,713 |
YZY Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
YZY Bio Patents
YZY Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026189439-A1 | Pharmaceutical composition comprising anti-epcam and cd3 bispecific antibody | Pending | 13-Mar-2025 | ||
| WO-2026011751-A1 | Antibody formulation | Pending | 08-Jul-2024 | ||
| WO-2025190337-A1 | Method for ameliorating or treating malignant ascites using anti-epcam × cd3 bispecific antibody | Pending | 13-Mar-2024 | ||
| WO-2024082269-A1 | Application of bispecific antibody in immune cell therapy | Inactive | 21-Oct-2022 | ||
| JP-7868145-B2 | Bispecific antibodies and their applications | Active | 19-Nov-2021 | C07K16/30 |
YZY Bio Signals
YZY Bio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
YZY Bio ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
YZY Bio FAQs
-
When was YZY Bio founded?
YZY Bio was founded in 2010.
-
Where is YZY Bio headquartered?
YZY Bio is headquartered in Wuhan, China.
-
What is the size of YZY Bio?
YZY Bio has 68 total employees.
-
What industry is YZY Bio in?
YZY Bio’s primary industry is Pharmaceuticals.
-
Is YZY Bio a private or public company?
YZY Bio is a Public company.
-
What is YZY Bio’s stock symbol?
The ticker symbol for YZY Bio is 02496.
-
What is the current stock price of YZY Bio?
As of 16-Nov-2026 the stock price of YZY Bio is $0.54.
-
What is the current market cap of YZY Bio?
The current market capitalization of YZY Bio is $107M.
-
What is YZY Bio’s current revenue?
The trailing twelve month revenue for YZY Bio is $8.98M.
-
What is YZY Bio’s annual earnings per share (EPS)?
YZY Bio’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process